BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23266473)

  • 1. Specific interactions between Epac1, β-arrestin2 and PDE4D5 regulate β-adrenergic receptor subtype differential effects on cardiac hypertrophic signaling.
    Berthouze-Duquesnes M; Lucas A; Saulière A; Sin YY; Laurent AC; Galés C; Baillie G; Lezoualc'h F
    Cell Signal; 2013 Apr; 25(4):970-80. PubMed ID: 23266473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK.
    Kobayashi H; Narita Y; Nishida M; Kurose H
    Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.
    Bolger GB; Baillie GS; Li X; Lynch MJ; Herzyk P; Mohamed A; Mitchell LH; McCahill A; Hundsrucker C; Klussmann E; Adams DR; Houslay MD
    Biochem J; 2006 Aug; 398(1):23-36. PubMed ID: 16689683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4.
    Richter W; Day P; Agrawal R; Bruss MD; Granier S; Wang YL; Rasmussen SG; Horner K; Wang P; Lei T; Patterson AJ; Kobilka B; Conti M
    EMBO J; 2008 Jan; 27(2):384-93. PubMed ID: 18188154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes.
    Shi Q; Li M; Mika D; Fu Q; Kim S; Phan J; Shen A; Vandecasteele G; Xiang YK
    Cardiovasc Res; 2017 May; 113(6):656-670. PubMed ID: 28339772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells.
    Lynch MJ; Baillie GS; Mohamed A; Li X; Maisonneuve C; Klussmann E; van Heeke G; Houslay MD
    J Biol Chem; 2005 Sep; 280(39):33178-89. PubMed ID: 16030021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, beta-arrestin and RACK1.
    Smith KJ; Baillie GS; Hyde EI; Li X; Houslay TM; McCahill A; Dunlop AJ; Bolger GB; Klussmann E; Adams DR; Houslay MD
    Cell Signal; 2007 Dec; 19(12):2612-24. PubMed ID: 17900862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5.
    Li X; Baillie GS; Houslay MD
    J Biol Chem; 2009 Jun; 284(24):16170-16182. PubMed ID: 19372219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
    Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
    J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Dependent Maturation of iPSC-CMs Leads to the Enhanced Compartmentation of β
    Hasan A; Mohammadi N; Nawaz A; Kodagoda T; Diakonov I; Harding SE; Gorelik J
    Cells; 2020 Oct; 9(10):. PubMed ID: 33053822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.
    Wang S; Gong H; Jiang G; Ye Y; Wu J; You J; Zhang G; Sun A; Komuro I; Ge J; Zou Y
    PLoS One; 2014; 9(4):e92926. PubMed ID: 24699426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.
    Bastug-Özel Z; Wright PT; Kraft AE; Pavlovic D; Howie J; Froese A; Fuller W; Gorelik J; Shattock MJ; Nikolaev VO
    Cardiovasc Res; 2019 Mar; 115(3):546-555. PubMed ID: 30165515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stress.
    Laudette M; Coluccia A; Sainte-Marie Y; Solari A; Fazal L; Sicard P; Silvestri R; Mialet-Perez J; Pons S; Ghaleh B; Blondeau JP; Lezoualc'h F
    Cardiovasc Res; 2019 Oct; 115(12):1766-1777. PubMed ID: 30873562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β
    Yang HQ; Wang LP; Gong YY; Fan XX; Zhu SY; Wang XT; Wang YP; Li LL; Xing X; Liu XX; Ji GS; Hou T; Zhang Y; Xiao RP; Wang SQ
    Circ Res; 2019 Apr; 124(9):1350-1359. PubMed ID: 30836825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
    Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
    Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway.
    Métrich M; Laurent AC; Breckler M; Duquesnes N; Hmitou I; Courillau D; Blondeau JP; Crozatier B; Lezoualc'h F; Morel E
    Cell Signal; 2010 Oct; 22(10):1459-68. PubMed ID: 20576488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDE4B mediates local feedback regulation of β₁-adrenergic cAMP signaling in a sarcolemmal compartment of cardiac myocytes.
    Mika D; Richter W; Westenbroek RE; Catterall WA; Conti M
    J Cell Sci; 2014 Mar; 127(Pt 5):1033-42. PubMed ID: 24413164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
    Métrich M; Lucas A; Gastineau M; Samuel JL; Heymes C; Morel E; Lezoualc'h F
    Circ Res; 2008 Apr; 102(8):959-65. PubMed ID: 18323524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRK5 Controls SAP97-Dependent Cardiotoxic β
    Xu B; Li M; Wang Y; Zhao M; Morotti S; Shi Q; Wang Q; Barbagallo F; Teoh JP; Reddy GR; Bayne EF; Liu Y; Shen A; Puglisi JL; Ge Y; Li J; Grandi E; Nieves-Cintron M; Xiang YK
    Circ Res; 2020 Aug; 127(6):796-810. PubMed ID: 32507058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.